Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

1.

Randomized trial of daily versus weekly administration of 2-chlorodeoxyadenosine in patients with hairy cell leukemia: a multicenter phase III trial (SAKK 32/98).

Zenhäusern R, Schmitz SF, Solenthaler M, Heim D, Meyer-Monard S, Hess U, Leoncini L, Bargetzi M, Rufener B, Tobler A.

Leuk Lymphoma. 2009 Sep;50(9):1501-11. doi: 10.1080/10428190903131755.

PMID:
19672771
2.

Long-term follow-up of 233 patients with hairy cell leukaemia, treated initially with pentostatin or cladribine, at a median of 16 years from diagnosis.

Else M, Dearden CE, Matutes E, Garcia-Talavera J, Rohatiner AZ, Johnson SA, O'Connor NT, Haynes A, Osuji N, Forconi F, Lauria F, Catovsky D.

Br J Haematol. 2009 Jun;145(6):733-40. doi: 10.1111/j.1365-2141.2009.07668.x. Epub 2009 Mar 29.

PMID:
19344416
3.

Recombinant immunotoxins containing truncated bacterial toxins for the treatment of hematologic malignancies.

Kreitman RJ.

BioDrugs. 2009;23(1):1-13. doi: 10.2165/00063030-200923010-00001. Review.

4.

Sweet syndrome as the presenting symptom of hairy cell leukemia.

Ventura F, Rocha J, Pereira T, Marques H, Pardal F, Brito C.

Dermatol Online J. 2009 Feb 15;15(2):12. No abstract available.

5.

Risk factors for severe infection in patients with hairy cell leukemia: a long-term study of 73 patients.

Damaj G, Kuhnowski F, Marolleau JP, Bauters F, Leleu X, Yakoub-Agha I.

Eur J Haematol. 2009 Sep;83(3):246-50. doi: 10.1111/j.1600-0609.2009.01259.x. Epub 2009 Mar 19.

PMID:
19302557
6.

Long-term follow-up of interferon-alpha induction and low-dose maintenance therapy in hairy cell leukemia.

Benz R, Siciliano RD, Stussi G, Fehr J.

Eur J Haematol. 2009 Mar;82(3):194-200. doi: 10.1111/j.1600-0609.2008.01190.x. Epub 2008 Dec 5.

PMID:
19077050
7.

Teenager with hairy cell leukemia: 30-year follow-up.

Kilbridge TM, Kadin ME.

J Clin Oncol. 2009 Jan 1;27(1):155-6. doi: 10.1200/JCO.2008.20.3372. Epub 2008 Dec 1. No abstract available.

PMID:
19047276
8.

Non-traumatic splenic rupture: report of seven cases and review of the literature.

Gedik E, Girgin S, Aldemir M, Keles C, Tuncer MC, Aktas A.

World J Gastroenterol. 2008 Nov 21;14(43):6711-6. Review.

9.

Soluble CD22 as a tumor marker for hairy cell leukemia.

Matsushita K, Margulies I, Onda M, Nagata S, Stetler-Stevenson M, Kreitman RJ.

Blood. 2008 Sep 15;112(6):2272-7. doi: 10.1182/blood-2008-01-131987. Epub 2008 Jul 2.

10.

Hairy cell leukemia: treatment successes in the past 25 years.

Golomb HM.

J Clin Oncol. 2008 Jun 1;26(16):2607-9. doi: 10.1200/JCO.2007.15.7420. No abstract available.

PMID:
18509168
11.

Successful treatment of warm antibody (IgG/C3 positive) autoimmune hemolytic anemia in hairy-cell leukemia with 2-CdA in the elderly.

Viens D, St-Hilaire E, Beauregard P, Dufresne J, Knecht H.

Leuk Lymphoma. 2008 Jul;49(7):1424-6. doi: 10.1080/10428190802074627. No abstract available.

PMID:
18452105
12.

High density genome-wide DNA profiling reveals a remarkably stable profile in hairy cell leukaemia.

Forconi F, Poretti G, Kwee I, Sozzi E, Rossi D, Rancoita PM, Capello D, Rinaldi A, Zucca E, Raspadori D, Spina V, Lauria F, Gaidano G, Bertoni F.

Br J Haematol. 2008 May;141(5):622-30. doi: 10.1111/j.1365-2141.2008.07106.x. Epub 2008 Apr 7.

PMID:
18397341
13.

Selective influences in the expressed immunoglobulin heavy and light chain gene repertoire in hairy cell leukemia.

Forconi F, Sozzi E, Rossi D, Sahota SS, Amato T, Raspadori D, Trentin L, Leoncini L, Gaidano G, Lauria F.

Haematologica. 2008 May;93(5):697-705. doi: 10.3324/haematol.12282. Epub 2008 Apr 2.

14.

Polyarteritis nodosa in hairy cell leukaemia: an autopsy report.

Vankalakunti M, Joshi K, Jain S, Nada R, Radotra BD, Varma S.

J Clin Pathol. 2007 Oct;60(10):1181-2. No abstract available.

15.

The role of rituximab in combination with pentostatin or cladribine for the treatment of recurrent/refractory hairy cell leukemia.

Else M, Osuji N, Forconi F, Dearden C, Del Giudice I, Matutes E, Wotherspoon A, Lauria F, Catovsky D.

Cancer. 2007 Nov 15;110(10):2240-7.

16.

Spontaneous splenic rupture in two patients with hematologic malignancy.

Szotkowski T, Szotkowska R, Pikalova Z, Tichy T, Flodr P, Tichy M, Houserkova D, Benysek V, Zlamalova N, Ruzicka V, Indrak K.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2007 Jun;151(1):113-6.

17.

Hairy cell leukemia.

Swords R, Giles F.

Med Oncol. 2007;24(1):7-15. Review.

PMID:
17673807
18.

Second cancer incidence and cause-specific mortality among 3104 patients with hairy cell leukemia: a population-based study.

Hisada M, Chen BE, Jaffe ES, Travis LB.

J Natl Cancer Inst. 2007 Feb 7;99(3):215-22.

PMID:
17284716
19.

Cladribine in a weekly versus daily schedule for untreated active hairy cell leukemia: final report from the Polish Adult Leukemia Group (PALG) of a prospective, randomized, multicenter trial.

Robak T, Jamroziak K, Gora-Tybor J, Blonski JZ, Kasznicki M, Dwilewicz-Trojaczek J, Wiater E, Zdunczyk A, Dybowicz J, Dmoszynska A, Wojtaszko M, Zdziarska B, Calbecka M, Kostyra A, Hellmann A, Lewandowski K, Stella-Holowiecka B, Sulek K, Gawronski K, Skotnicki AB, Nowak W, Zawilska K, Molendowicz-Portala L, Kloczko J, Sokolowski J, Warzocha K, Seferynska I, Ceglarek B, Konopka L.

Blood. 2007 May 1;109(9):3672-5. Epub 2007 Jan 5.

20.

Immunotoxins in the treatment of refractory hairy cell leukemia.

Kreitman RJ, Pastan I.

Hematol Oncol Clin North Am. 2006 Oct;20(5):1137-51, viii. Review.

PMID:
16990113

Supplemental Content

Support Center